Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients

Peter Stastny, Steves Ring, Christopher Lu, Juan Arenas, Mei Han, Bhavna Lavingia

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Antibodies against HLA antigens offer a window to the response of transplant recipients to the challenge of allografts. HLA alleles produced by recombinant technology and attached to color-coded polystyrene microspheres are now in widespread use. They offer antibody detection by flow cytometry at a high level of sensitivity. Methods used in the author's laboratory for the interpretation of these tests are described. They include a correction for variable antigen density, and the binding of normal immunoglobulins to the conjugated beads. The 'normalized ratio' provides a good method of scoring results. Antibodies specific for the antigens of the donors were associated with kidney and heart allograft loss. Antibodies against crossreactive antigens, without reactivity against donor HLA, did not appear to increase the risk of developing chronic rejection. Antibody production by peripheral blood B cells was analyzed. The idea of sequestration of HLA antibodies in the graft as a major cause for their absence in the blood after transplantation is discussed. IgM antibodies against donor HLA antigens were found before transplantion and also were produced both early and late in the post-transplant course. In addition, IgM antibodies against donor HLA appeared to be associated with decreased survival of kidney and heart allografts.

Original languageEnglish (US)
Pages (from-to)600-604
Number of pages5
JournalHuman Immunology
Volume70
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

HLA Antigens
Immunoglobulin M
Immunoglobulin G
Transplants
Antibodies
Allografts
Tissue Donors
Antigens
Kidney
Polystyrenes
Transplant Recipients
Microspheres
Antibody Formation
Immunoglobulins
Blood Cells
Flow Cytometry
B-Lymphocytes
Research Design
Color
Transplantation

Keywords

  • antibody sequestration
  • donor-specific antibodies
  • IgG anti-HLA
  • IgM anti-HLA

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. / Stastny, Peter; Ring, Steves; Lu, Christopher; Arenas, Juan; Han, Mei; Lavingia, Bhavna.

In: Human Immunology, Vol. 70, No. 8, 08.2009, p. 600-604.

Research output: Contribution to journalArticle

@article{5edcb1845f3a4165b2e68553f6c70e51,
title = "Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients",
abstract = "Antibodies against HLA antigens offer a window to the response of transplant recipients to the challenge of allografts. HLA alleles produced by recombinant technology and attached to color-coded polystyrene microspheres are now in widespread use. They offer antibody detection by flow cytometry at a high level of sensitivity. Methods used in the author's laboratory for the interpretation of these tests are described. They include a correction for variable antigen density, and the binding of normal immunoglobulins to the conjugated beads. The 'normalized ratio' provides a good method of scoring results. Antibodies specific for the antigens of the donors were associated with kidney and heart allograft loss. Antibodies against crossreactive antigens, without reactivity against donor HLA, did not appear to increase the risk of developing chronic rejection. Antibody production by peripheral blood B cells was analyzed. The idea of sequestration of HLA antibodies in the graft as a major cause for their absence in the blood after transplantation is discussed. IgM antibodies against donor HLA antigens were found before transplantion and also were produced both early and late in the post-transplant course. In addition, IgM antibodies against donor HLA appeared to be associated with decreased survival of kidney and heart allografts.",
keywords = "antibody sequestration, donor-specific antibodies, IgG anti-HLA, IgM anti-HLA",
author = "Peter Stastny and Steves Ring and Christopher Lu and Juan Arenas and Mei Han and Bhavna Lavingia",
year = "2009",
month = "8",
doi = "10.1016/j.humimm.2009.04.017",
language = "English (US)",
volume = "70",
pages = "600--604",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients

AU - Stastny, Peter

AU - Ring, Steves

AU - Lu, Christopher

AU - Arenas, Juan

AU - Han, Mei

AU - Lavingia, Bhavna

PY - 2009/8

Y1 - 2009/8

N2 - Antibodies against HLA antigens offer a window to the response of transplant recipients to the challenge of allografts. HLA alleles produced by recombinant technology and attached to color-coded polystyrene microspheres are now in widespread use. They offer antibody detection by flow cytometry at a high level of sensitivity. Methods used in the author's laboratory for the interpretation of these tests are described. They include a correction for variable antigen density, and the binding of normal immunoglobulins to the conjugated beads. The 'normalized ratio' provides a good method of scoring results. Antibodies specific for the antigens of the donors were associated with kidney and heart allograft loss. Antibodies against crossreactive antigens, without reactivity against donor HLA, did not appear to increase the risk of developing chronic rejection. Antibody production by peripheral blood B cells was analyzed. The idea of sequestration of HLA antibodies in the graft as a major cause for their absence in the blood after transplantation is discussed. IgM antibodies against donor HLA antigens were found before transplantion and also were produced both early and late in the post-transplant course. In addition, IgM antibodies against donor HLA appeared to be associated with decreased survival of kidney and heart allografts.

AB - Antibodies against HLA antigens offer a window to the response of transplant recipients to the challenge of allografts. HLA alleles produced by recombinant technology and attached to color-coded polystyrene microspheres are now in widespread use. They offer antibody detection by flow cytometry at a high level of sensitivity. Methods used in the author's laboratory for the interpretation of these tests are described. They include a correction for variable antigen density, and the binding of normal immunoglobulins to the conjugated beads. The 'normalized ratio' provides a good method of scoring results. Antibodies specific for the antigens of the donors were associated with kidney and heart allograft loss. Antibodies against crossreactive antigens, without reactivity against donor HLA, did not appear to increase the risk of developing chronic rejection. Antibody production by peripheral blood B cells was analyzed. The idea of sequestration of HLA antibodies in the graft as a major cause for their absence in the blood after transplantation is discussed. IgM antibodies against donor HLA antigens were found before transplantion and also were produced both early and late in the post-transplant course. In addition, IgM antibodies against donor HLA appeared to be associated with decreased survival of kidney and heart allografts.

KW - antibody sequestration

KW - donor-specific antibodies

KW - IgG anti-HLA

KW - IgM anti-HLA

UR - http://www.scopus.com/inward/record.url?scp=68049147284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049147284&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2009.04.017

DO - 10.1016/j.humimm.2009.04.017

M3 - Article

C2 - 19375468

AN - SCOPUS:68049147284

VL - 70

SP - 600

EP - 604

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 8

ER -